Log in
Enquire now
‌

US Patent 11607451 Self-buffering antibody formulations

Patent 11607451 was granted and assigned to Amgen on March, 2023 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
Amgen
Amgen
0
Current Assignee
Amgen
Amgen
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
116074510
Patent Inventor Names
Richard Louis Remmele, Jr.0
Eva Kras0
David Brems0
Susan Irene Hershenson0
Yatin R. Gokarn0
Date of Patent
March 21, 2023
0
Patent Application Number
137976220
Date Filed
March 12, 2013
0
Patent Citations
‌
US Patent 10307483 Pharmaceutical formulations and methods of making the same
0
Patent Primary Examiner
‌
Sean E Aeder
0
CPC Code
‌
A61K 51/04
0
‌
A61K 51/10
0
‌
A61K 51/1093
0
‌
A61K 39/00
0
‌
A61K 47/00
0
‌
A61K 47/02
0
‌
A61K 47/10
0
‌
A61K 47/26
0
...

The invention herein described, provides, among other things, self-buffering protein formulations. Particularly, the invention provides self-buffering pharmaceutical protein formulations that are suitable for veterinary and human medical use. The self-buffering protein formulations are substantially free of other buffering agents, stably maintain pH for the extended time periods involved in the distribution and storage of pharmaceutical proteins for veterinary and human medical use. The invention further provides methods for designing, making, and using the formulation. In addition to other advantages, the formulations avoid the disadvantages associated with the buffering agents conventionally used in current formulations of proteins for pharmaceutical use. The invention in these and other respects can be productively applied to a wide variety of proteins and is particularly useful for making and using self-buffering formulations of pharmaceutical proteins for veterinary and medical use, especially, in particular, for the treatment of diseases in human subjects.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11607451 Self-buffering antibody formulations

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.